Stringhini, S., Wisniak, A., Piumatti, G., Azman, A., Lauer, S., and H. Baysson. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. (2020). 
*https://doi.org/10.1016/S0140-6736(20)31304-0

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

University of Michigan - Ann Arbor

- Journal of American Medical Association (JAMA)
- The Lancet
- MedRxiv preprint

References for SARS-CoV-2 Antibody Testing by Journal/Source

- Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium

Journal of American Medical Association (JAMA) Papers Related to SARS-CoV-2 Antibody Testing

The Lancet Papers Related to SARS-CoV-2 Antibody Testing

-  Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients
- SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months
-  Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan–[negative] implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2
- Comparative performance of five commercially available serologic assays to detect antibodies to SARS-coV-2 and identify individuals with high neutralizing titers. 

Learn Before

Related

Learn After